• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of abnormal expression of complement activation-regulatory proteins in the pathogenesis of intestinal mucosal damages

Research Project

Project/Area Number 09670541
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionShiga University of Medical Science

Principal Investigator

SATOME Takao (1999)  Shiga University of Medical Science, Assistant Professor, 医学部, 助手 (60311726)

安藤 朗 (1997-1998)  滋賀医科大学, 医学部, 助手 (90252395)

Co-Investigator(Kenkyū-buntansha) ANDOH Akira  Shiga University of Medical Science, Assistant Professor, 医学部, 助手 (90252395)
五月女 隆男  滋賀医科大学, 医学部, 助手
Project Period (FY) 1997 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1999: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1998: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1997: ¥1,000,000 (Direct Cost: ¥1,000,000)
Keywordscomplement / Inflammatory bowel disease / DAF / butyrate / DAF / サイトカイン / 腸管粘膜 / Complement / Cytokine
Research Abstract

The secretory IgA system has been established as a potent immunological protection system in the intestinal tract. In addition, we have reported that high amounts of complement proteins are secreted into the intestinal tract from bile and pancreatic juice. Furthermore, we have found that intestinal epithelial cells are local biosynthetic site for complement proteins. Thus, complement system plays an important role in the immunologic protection in the intestinal mucosa. However, complement activation induces the mucosal damages by itself, and intestinal epithelial cells are expressing several complement activation regulatory proteins to protect from complement-mediated cell injury. Decay-accelerating factor (DAF) is one of complement activation regulatory proteins of which expression are induced by TNF-α and IL-4. In this study, we attempted to define the pathogenesis of inflammatory bowel disease in the aspects of the abnormal expression of complement regulatory proteins. Our study for these three years demonstrated several novel findings. At first, DAF expression was increased in the inflamed mucosa of ulcerative colitis (UC) patients. As second, DAF expression is induced by TNF-α and IL-4, but decreased by sodium butyrate. Third, sodium butyrate increased complement C3 secretion in intestinal epithelial cells. From these results, we concluded that butyrate, one of short-chain fatty acids generated by bacterial fermentation, plays an important role in the regulatory mechanisms of complement protein secretion and complement regulatory-protein expression in the intestinal epithelial cells. It is likely that the control of bacterial fermentation may be one of effective therapeutic strategies in the treatment of IBD patients.

Report

(4 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Akira Andoh: "Comp**-regulatry effect of solium butyrate on tumor necrosis factor alpha(TNF-α)-induced complement C3 and factor B biosynthesis in human intestinal epitheliac cells"Clinical and Experimental Immunology. 118. 23-29 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Akira Andoh: "Rapid in testinal ichemia-reperfusion injury is suppressed ingenetically mast cell-deficient Ws/Ws rats"Clinical and Experimental Immunology. 116. 90-93 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Akira Andoh: "Physiological and anti-inflammatory roles and dietary fiber and butyrate in intesbinal functions"J. Parenteral and Enteral Nutrtion. 23. 70-73 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Kitamura: "Solidum butyrate blocks interferon-gamma(IFN-γ)induced biosynthesis of MHC class III gene products(coplement C4 and faeTirB) in human fetal intestinal epithelial cells"Clinical and Experimental Immunology. 118. 16-22 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y. Araki: "Development of dextran salphat sodium(Dis) induced experimental *lites is supressed in genetically mast cell-deficient Ws/Ws rats"Clinical and Experimental Immunology. 119. 264-269 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] A. Andoh, Y. Fujiyama, K. Hata, Y. Araki, H. Takaya, M. Shimada, T. Bamba: "Counter-regulatory effect of sodium butyrate on tumor necrosis factor-alpha (TNF-α)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells"Clin. Exp. Immunol.. 118. 23-29 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] A. Andoh, T. Kimura, M. Fukuda, Y. Araki, Y. Fujiyama, T. Bamba: "Rapid intestinal ischema-reperfusion injury is suppressed in genetically mast cell-deficient Ws/Ws rats"Clin. Exp. Immunol.. 116. 90-93 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] A. Andoh, T. Bamba, M. Sasaki: "Physiological and anti-inflammatory roles and dietary fiber and butyrate in intestinal functions"JPEN J. Parenter. Enteral Nutr.. 23. 70-73 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Kitamura, A. Andoh, T. Inoue, Y. Amakata, K. Hodohara, Y. Fujiyama, T. Bamba: "Sodium Butyrate blocks interferon-gamma (IFN-γ)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells"Clin. Exp. Immunol.. 118. 16-22 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y. Araki, A. Andoh, Y. Fujiyama, T. Bamba: "Development of dextran sulphate sodium (DSS)-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats"Clin. Exp. Immunol.. 119. 264-269 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Akira Andoh: "Counter-regulatory effect of sodium butyrate on tumor necrosis factor alpha(TNF-α)-induced complement C_3 and factorB biosynthesis in human intestinal epithelial cells"Clinical and Experimental Immunology. 118. 23-29 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Akira Andoh: "Rapid intestinal ischemia-reperfusion injury is suppressed in genetically most cell-deficient Ws-Ws rats"Clinical and Experimental Immunology. 116. 90-93 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Akira Andoh: "Physiological and anti-inflammatory roles and dietary fiber and butyrate in intestinal functions"J.Parenteral and Enteral Nutrition. 23. 70-73 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Kitamura: "Sodium Butyrate blocks interferon-gamma(IFN-γ) induced biosynthesis of MHC class III gene products (complement C_4 and factor B) in human fetal intestinal epithelial cells"Clinical and Experimental Immunology. 118. 16-22 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Y.Araki: "Development of dextran sulphate Sodium (DSS)-induced experimental colitis is suppressed in genetically most cell-deficient Ws/Ws rats"Clinical and Experimental Immunology. 119. 264-269 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Akira Andoh: "Detection of Complement C3 and Factor B Gene Expression in Normal Colorectal Mucosa, adenomas and Carcinomas" Clinical and Experimental Immunology. 111. 477-483 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Akira Andoh: "Increased expression of decay-accereleting factor(CD55)in the inflamed mucosa of patients with Ulcerative Colitis" Pathophysiology. 5. 105-110 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Akira Andoh: "Primary gastric Burlitt′s ly-phoma presenting with C-myc gene rearrangement" J Gastroenterology. 33. 710-715 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Akira Andoh: "Molecular Characterization of Complement Components (C3,C4,and Factor B) in Human Saliva." Journal of Clinical Immunology. 17(5). 404-407 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Akira Andoh: "Detection of Complement C3 and Factor B Gene Expression in Normal Colorectal Mucosa,Adenomas and Carcinomas." Clinical and Experimental Immunology. 111(3). 477-483 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] Akira Andoh: "Tumor Necrosis Factor-α and Interleukin-4 induces decy-acceleniting Factor Gene Expression in Intestinal Epithe Lial Cells by ・・・・." Mucosal Solutions,Advances in Mucosal Immunology,. Vol.1. 75-83 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] Toshio Kimura: "A blockade of complenent activation prevents rapld intestinal lschemia-qperfnsion injury by modulating ・・・・." Clinical and Experimental Immunology. 111(3). 484-490 (1998)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi